Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease-First, Do No Harm

Abstract

This article reports the results of an updated meta-analysis of 15 observational studies reporting the outcomes of 47 480 patients with atrial fibrillation and end-stage renal disease according to whether they were or were not treated with warfarin.

Citation
Belley-Cote EP and Eikelboom JW. JAMA Netw Open 2020;3(4):e202237.